Comparative analysis of therapeutic efficiency and costs (experience in Bulgaria) of oral antidiabetic therapies based on glitazones and gliptins
Crossref DOI link: https://doi.org/10.1186/s13098-015-0059-7
Published Online: 2015-07-16
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Filipova, Elena Pavlova
Uzunova, Katya Hristova
Vekov, Toni Yonkov
License valid from 2015-07-16
Article History
Received: 6 April 2015
Accepted: 8 July 2015
First Online: 16 July 2015